Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Study of RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha Therapy

ClinicalTrials.gov ID: NCT03001219

Public ClinicalTrials.gov record NCT03001219. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 9:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase II Study to Evaluate The Safety and Efficacy of RO7123520 as Adjunct Treatment in Patients With Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to TNF-alpha Inhibitors

Study identification

NCT ID
NCT03001219
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
109 participants

Conditions and interventions

Interventions

  • Anti-TNF-alpha Drug
  • Methotrexate Drug
  • Placebo Drug
  • RO7123520 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 21, 2016
Primary completion
Nov 5, 2018
Completion
Nov 5, 2018
Last update posted
Jan 28, 2020

2016 – 2018

United States locations

U.S. sites
32
U.S. states
14
U.S. cities
28
Facility City State ZIP Site status
Pinnacle Research Group; Llc, Central Anniston Alabama 36207
Arizona Arthritis & Rheumatology Associates, P.C. Glendale Arizona 85306
Arizona Arthritis and Rheuma Mesa Arizona 85202
Arizona Arthritis & Rheumatology Research, PLLC Phoenix Arizona 85037
Medvin Clinical Research Covina California 91723
University of California San Diego La Jolla California 92093
Advanced Medical Research, LLC Lakewood California 90712
Stanford hospital & Clinics; Investigational Drug Services Stanford California 94304
Omega Research Consultants LLC DeBary Florida 32713-1817
San Marcus Research Clinic, Inc. Hialeah Florida 33015-5110
Millenium Research Ormond Beach Florida 32174
Clinical Pharmacology Study Group Worcester Massachusetts 01610
Shores Rheumatology PC Saint Clair Shores Michigan 48080
Arthritis & Osteoporosis Associates Freehold New Jersey
Atlantic Coast Rheumatology Toms River New Jersey 08755
Ocean Rheumatology Toms River New Jersey 08775
Albuquerque Center For Rheumatology Albuquerque New Mexico 87102
Albuquerque Clinical Trials Albuquerque New Mexico 87102
Saint Lawrence Health System; Rheumatology Canton New York 13617
Paramount Medical Research Middleburg Heights Ohio 44130
Altoona Center For Clinical Research Duncansville Pennsylvania 16635
Advanced Rheumatology & Arthritis Research Center Wexford Pennsylvania 15090
Low Country Rheumatology, PA Charleston South Carolina 29406
Columbia Arthritis Center (Partnership Practice) Columbia South Carolina 29204
West Tennessee Research Institute Jackson Tennessee 38305
Adriana Pop-Moody MD Clinic PA Corpus Christi Texas 78404
Metroplex Clinical Research Dallas Texas 75231
Pioneer Research Solutions Houston Texas 077099
Accurate Clinical Research Houston Texas 77058-3675
Accurate Clinical Research Houston Texas 77089
Southwest Rheumatology Mesquite Texas 75150
Accurate Clinical Research, Inc Stafford Texas 77477

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03001219, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 28, 2020 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03001219 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →